What is VirtualScopics?
VirtualScopics specializes in delivering clinical trial imaging solutions designed to streamline the complex processes involved in drug and medical device development. The company targets risk-averse, time-constrained clinical trial study teams, medical directors, and imaging scientists who demand high-quality imaging data delivered punctually and within budgetary constraints. VirtualScopics distinguishes itself by offering a level of scientific and operational flexibility and responsiveness that sets it apart from conventional clinical trial imaging providers, thereby delivering substantial performance advantages over competitors offering standard imaging services.
How much funding has VirtualScopics raised?
VirtualScopics has raised a total of $3M across 1 funding round:
Private Equity
$3M
Private Equity (2012): $3M, investors not publicly disclosed
What's next for VirtualScopics?
The substantial enterprise-level funding indicates a strategic phase for VirtualScopics, likely focused on scaling its operational capacity, expanding its technological infrastructure, and potentially broadening its market reach. This capital infusion is expected to fortify its position in the competitive clinical trial services sector, enabling further innovation in imaging analytics and data management to support the evolving needs of pharmaceutical and biotechnology companies.
See full VirtualScopics company page
